State of the science on mild cognitive impairment (MCI)

Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10–15% of the population over the age of 65. The failure of drug trials in Alzheimer’s disease (AD) treatment has shifted researchers’ focus toward delaying progression from MCI to dementi...

Full description

Saved in:

Bibliographic Details
Published in:	CNS spectrums Vol. 24; no. 1; pp. 78 - 87
Main Author:	Anderson, Nicole D.
Format:	Journal Article
Language:	English
Published:	United States Cambridge University Press 01.02.2019
Subjects:	Alzheimer's disease Apolipoproteins - genetics Apolipoproteins - metabolism Biomarkers Cognitive Dysfunction - drug therapy Cognitive Dysfunction - genetics Cognitive Dysfunction - metabolism Cognitive Dysfunction - physiopathology Cortical Excitability Humans Mental depression Nootropic Agents - therapeutic use Older people neuropsychological assessment exercise and diet interventions biomarkers tau Amyloid mild cognitive impairment memory strategy training neuroimaging
ISSN:	1092-8529, 2165-6509
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!